Work

The Role of Tralokinumab in the Treatment of Atopic Dermatitis and Future Perspectives for Adolescents

Year: 2023

Type: review

Source: Immunotherapy

DOI: 10.2217/imt-2022-0307

Authors: Adaora R Ewulu, Stuti Prajapati, Steven R Feldman

Institutions: Wake Forest University Health Sciences, Wake Forest University, University of Southern Denmark

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, National Psoriasis Foundation, Eli Lilly and Company, Pfizer, Celgene, Biocon, Helsinn, Regeneron Pharmaceuticals, Mylan, Argenx, Australian Renewable Energy Agency, Forskningsrådet om Hälsa, Arbetsliv och Välfärd, Galderma, Sun Pharma, Almirall, LEO Pharma, Janssen Biotech

OpenAlex ID: W4386245689

FWCI: 0.517

Cites: 38

Cited by: 12

Related to: 10